Insider · CIK 0001550337
Theodore S. Hanson
ceoofficerdirector
Files at EFOR (ASGN Inc). First filing Nov 14, 2024, latest Nov 14, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $207k sold
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 12, 2024 | EFOR ASGN Inc | 53,000 0.12% of outstanding | $5.3M | Nov 12, 2024 | none |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | EFOR ASGN Inc | AGrant or award Common Stock | +68,581 | $46.66 | $3.2M | 128,081 | Jan 6, 2026 |
| Jan 2, 2026 | EFOR ASGN Inc | FTax withholding Common Stock | -9,744 | $46.66 | $455k | 118,337 | Jan 6, 2026 |
| Feb 6, 2025 | EFOR ASGN Inc | AGrant or award Common Stock | +9,093 | $82.73 | $752k | 81,870 | Feb 10, 2025 |
| Feb 6, 2025 | EFOR ASGN Inc | FTax withholding Common Stock | -4,101 | $82.73 | $339k | 77,769 | Feb 10, 2025 |
| Jan 2, 2025 | EFOR ASGN Inc | AGrant or award Common Stock | +36,205 | $82.86 | $3.0M | 80,666 | Jan 6, 2025 |
| Jan 2, 2025 | EFOR ASGN Inc | FTax withholding Common Stock | -7,889 | $82.86 | $654k | 72,777 | Jan 6, 2025 |
| Nov 12, 2024 | EFOR ASGN Inc | SOpen-market sale Common Stockindirect: by Trust | -1,200 | $99.64 | $120k | 288,855 | Nov 14, 2024 |
| Nov 13, 2024 | EFOR ASGN Inc | SOpen-market sale Common Stockindirect: by Trust | -900 | $97.12 | $87k | 287,955 | Nov 14, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.